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ARTICLE
The podoplanin-CLEC-2 axis inhibits inﬂammation
in sepsis
Julie Rayes1, Siân Lax1, Surasak Wichaiyo1, Stephanie K. Watson1, Ying Di1, Stephanie Lombard1,
Beata Grygielska1, Stuart W. Smith2, Kassiani Skordilis3 & Steve P. Watson1,4,5
Platelets play a critical role in vascular inﬂammation through the podoplanin and collagen/
ﬁbrin receptors, C-type-lectin-like-2 (CLEC-2) and glycoprotein VI (GPVI), respectively. Both
receptors regulate endothelial permeability and prevent peri-vascular bleeding in inﬂamma-
tion. Here we show that platelet-speciﬁc deletion of CLEC-2 but not GPVI leads to enhanced
systemic inﬂammation and accelerated organ injury in two mouse models of sepsis–intra-
peritoneal lipopolysaccharide and cecal ligation and puncture. CLEC-2 deﬁciency is asso-
ciated with reduced numbers of podoplanin-expressing macrophages despite increased
cytokine and chemokine levels in the infected peritoneum. Pharmacological inhibition of the
interaction between CLEC-2 and podoplanin regulates immune cell inﬁltration and the
inﬂammatory reaction during sepsis, suggesting that activation of podoplanin underlies the
anti-inﬂammatory action of platelet CLEC-2. We suggest podoplanin-CLEC-2 as a novel anti-
inﬂammatory axis regulating immune cell recruitment and activation in sepsis.
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Sepsis is a life-threatening, severe systemic inﬂammatoryresponse associated with multiple organ failure and death,which affects over 19 million patients annually1,2. Multi-
organ failure results from excessive activation of complement,
coagulation, and inﬂammation, making it likely that successful
therapeutic intervention will require combination therapy3,4. In
line with this, clinical trials targeting cytokines (e.g., anti-tumor
necrosis factor (TNF)-α), bacterial virulence factors or coagula-
tion factors have failed to show beneﬁt in sepsis-mediated
mortality5.
Therapeutic strategies targeting inﬂammation in sepsis must
also preserve the role of the inﬂammatory reaction in mediating
bacterial clearance. In peritonitis, clearance of bacteria depends
on recruitment and activation of neutrophils and monocytes/
macrophages6–8. Using a model of bacterial peritonitis combined
with neutrophil depletion, it has previously been shown that
while neutrophils regulate the early immune response, lacking
them does not alter mortality, due to inﬂammatory macrophages
increasing their anti-bacterial activity7,9. This has been shown to
be due to the role of neutrophils suppressing monocyte activation
via interleukin (IL)-1010. In contrast, combined monocyte and
neutrophil ablation signiﬁcantly increases bacterial load, inﬂam-
matory cytokines and septic lethality during cecal ligation and
puncture (CLP)10. These data demonstrate a critical role for
neutrophils and macrophages in regulating the severity of sepsis.
Platelets are now recognized to play a critical role in innate and
adaptive immunity11. Platelets engulf and kill bacteria12, and
protect against lipopolysaccharide (LPS)-induced septic shock by
regulating macrophage function13. In a large cohort of septic
patients, thrombocytopenia was associated with elevated levels of
IL-8, IL-6, and IL-10, increased complement signaling, endothe-
lial dysfunction, loss of vascular integrity, and increased mortal-
ity14. Thrombocytopenia is also associated with a poor outcome
during infection in patients with sepsis-induced acute kidney
injury (AKI)15,16.
Platelets regulate endothelial permeability and peri-vascular
bleeding during inﬂammation and infection17,18. This protective
role is predominantly mediated by the immunoreceptor tyrosine-
based activation motif (ITAM)-containing receptors, CLEC-2)
and glycoprotein (GP)VI19,20. Podoplanin, the only known
endogenous receptor for CLEC-2, is widely expressed on a variety
of epithelial surfaces, including kidney podocytes21 and alveolar
type 1 cells22, ﬁbroblastic reticular cells23, lymphatic endothelial
cells24, and is upregulated on inﬂammatory macrophages25,26 and
Th17 T cells27 during inﬂammation, and on tumor cells28. The
GPVI ligands collagen and ﬁbrin are present in the sub-
endothelium and on luminal surfaces, respectively, and partici-
pate in platelet and leukocyte recruitment to the inﬂamed glo-
meruli29 and in thrombus formation and stability30,31.
Recently, we demonstrated a novel role for the podoplanin-
CLEC-2 axis in driving thrombosis in liver during a mouse model
of Salmonella infection32 and during sterile inﬂammation, in a
mouse model of deep vein thrombosis (DVT)33. In these two
models, podoplanin was shown to be up-regulated in the sub-
endothelial wall and to become exposed at sites of breach thereby
triggering platelet activation and thrombus formation, a process
that has been termed thromboinﬂammation. Loss of platelet
CLEC-2 prevents the inﬂammation-driven thrombosis in both
models32,33. However, the role of CLEC-2 and podoplanin in the
preceding inﬂammation is not known.
Based on the previously reported role of platelets during sepsis,
and the upregulation of podoplanin on inﬂammatory macro-
phages, we hypothesize that CLEC-2 on platelets may also play a
role in the early inﬂammatory events that gives rise to sepsis. In
this study we have investigated this using two mouse models of
sepsis, intraperitoneal (i.p.)-LPS and CLP. Using transgenic
mouse strains, we demonstrate a protective role for platelet-
expressed CLEC-2 in regulating the inﬂammatory reaction and
preserving organ function in the two sepsis models. We further
demonstrate that pharmacological blockade of the CLEC-2-
podoplanin axis regulates the inﬂammatory reaction and immune
cell inﬁltration during sepsis. Taken together these data suggest
that the CLEC-2-podoplanin pathway plays a critical role in
limiting inﬂammation during sepsis.
Results
Thrombocytopenia accelerates LPS-induced-organ damage.
Previously published data demonstrate that LPS injection in mice
increases the clinical severity of sepsis and induces thrombocy-
topenia, leukocyte inﬁltration, dysregulation of the coagulation
cascade and thrombus formation in multiple tissues as well as
sequential multiple organ failure9,11,13. We ﬁrst conﬁrmed that i.
p. LPS induces thrombocytopenia and leukopenia (Fig. 1a, b) and
progressively increases multiple organ damage (Fig. 1c). A
decrease in liver and kidney function was observed 8 h post LPS
that was further decreased after 24 h as measured by a hypoal-
buminemia and an increase in plasma levels of sera alanine
transferase (ALT) and blood urea nitrogen (BUN) (Fig. 1d–f).
The decrease in liver and kidney function was associated with
thrombus formation in multiple vessels (Fig. 1g, h). In the kidney,
a network of ﬁbrin and platelet-associated ﬁbrin was observed in
the glomeruli and peritubular capillary along with podocyte
detachment in the Bowman’s space and adjacent tubules (Fig. 1h).
Platelets have been shown to protect against septic shock and
to decrease organ damage in mice during LPS-induced sepsis13.
In conﬁrmation of this, reducing the platelet count below 30 ×
109/L by injection of an antibody to GPIbα resulted in an increase
in clinical score (based on piloerection, reduced motor activity,
increased lethargy and an increased incidence of an intermittent
hunched posture; Supplementary Table 1) compared to isotype-
treated controls (Fig. 1i). Moreover, thrombocytopenia acceler-
ates organ function decline with a signiﬁcant increase in LDH,
ALT, and BUN 8 h post LPS compared to control mice (Fig. 1j–l).
Thus our data conﬁrm that platelets limit LPS-mediated sepsis
and protect from multiple organ damage.
Platelet CLEC-2 limits LPS-induced multiple organ damage.
We next assessed the role of the platelet ITAM receptors CLEC-2
and GPVI in LPS-mediated organ injury using CLEC-2-deﬁcient
(CLEC2ﬂ/ﬂPF4cre+), GPVI-deﬁcient (GPVI−/−) and mice deﬁ-
cient in both receptors (CLEC2ﬂ/ﬂPF4cre + GPVI−/−). In
unchallenged mice, deletion of CLEC-2, GPVI or both receptors
did not alter ALT or BUN level (Supplementary Fig. 1a, b).
Double-deﬁcient animals demonstrated a signiﬁcant decrease in
blood albumin levels compared to control mice indicative of mild
changes in kidney ﬁltration (Supplementary Fig. 1c). Moreover,
deletion of CLEC-2, but not GPVI, impairs vascular integrity in
the peritoneum as measured by hemoglobin levels in the perito-
neal lavage of unchallenged mice (Supplementary Fig. 1d). This
was also seen in double-deﬁcient animals.
Following LPS injection, a 30–50% drop in platelet count is
observed in all mouse strains used, which was associated with
leukopenia, suggesting that LPS-induced thrombocytopenia is
independent of CLEC-2 and GPVI expression (Supplementary
Fig. 2). Platelet-depleted, CLEC2ﬂ/ﬂPF4cre+ and CLEC2ﬂ/ﬂPF4cre
+ GPVI−/−, but not GPVI−/− mice, showed a rapid and signiﬁcant
increase in clinical severity relative to controls in response to LPS,
with a reduction in motor activity, increased lethargy and an
increased incidence of an intermittent hunched posture observed
(Fig. 2a).
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The enhanced clinical severity observed in platelet-depleted
and CLEC2ﬂ/ﬂPF4cre+ mice was associated with a decrease in
liver and kidney function at 8 h as assessed by LDH, blood
albumin, BUN and ALT 8 h post LPS (Fig. 2b–e). The decrease
in kidney function in CLEC2ﬂ/ﬂPF4cre+ was associated with an
increase in glomeruli congestion, apoptotic/necrotic podocytes
and epithelial cells, red cells and ﬁbrin deposition in the
Bowman’s space (Fig. 2f–h). In contrast, no signiﬁcant
difference in ﬁbrin deposition in the kidney was observed in
CLEC2ﬂ/ﬂPF4cre+ mice (Fig. 2i, j). Moreover, thrombus
formation in the liver of CLEC2ﬂ/ﬂPF4cre+ mice was not
affected (Fig. 2k). This was consistent with the absence of
podoplanin in the (peri-)vascular areas cells (Supplementary
Fig. 3).
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CLEC2ﬂ/ﬂPF4cre + GPVI−/− mice only demonstrated increases
in blood albumin and BUN with LDH and ALT levels comparable
to WT mice. Kidney histology indicated an intermediate
phenotype with a reduction in glomerular and tubular injury
compared to CLEC2ﬂ/ﬂPF4cre+ mice (Fig. 2f–h). This suggests
that GPVI deletion reverse the deleterious effect observed in
CLEC2ﬂ/ﬂPF4cre+ mice and that the degree of organ damage
does not correlate with the degree of blood-lymphatic mixing or
the level of hemoglobin in the peritoneal cavity, which are more
severe in the double-deﬁcient mice (Supplementary Fig. 1d).
In the lung, leukocyte inﬁltration was only observed around
the bronchioles of CLEC2ﬂ/ﬂPF4cre+ and CLEC2ﬂ/ﬂPF4cre +
GPVI−/− mice following LPS injection, with a proportion of the
inﬁltrating CD45+ cells expressing podoplanin (Fig. 2l, m).
Unchallenged CLEC2ﬂ/ﬂPF4cre+ and CLEC2ﬂ/ﬂPF4cre +
GPVI−/− have a mild reduction in platelet count compared to
their littermate controls. To address whether the mild thrombo-
cytopenia could account for the increase in severity in response to
i.p.-LPS, we reduced the platelet count to ~350–600 × 103/mm3
using an intermediate concentration of the GPIbα-depleting
antibody. We observed no difference in clinical score, ALT or
BUN levels compared to isotype-treated WT mice conﬁrming
that the mild thrombocytopenia does not underlie the increase in
organ damage (Supplementary Fig. 4).
Taken together these results suggest that CLEC-2 deletion from
platelets increases the severity of LPS-induced sepsis, which is
accompanied by an increase in multiple organ injury.
Podoplanin on podocytes does not alter LPS-induced AKI.
Podoplanin, the only known endogenous ligand for CLEC-2, is
strongly expressed by renal podocytes. We used a podocyte-
speciﬁc cre recombinase crossed to a ﬂoxed podoplanin strain,
PDPNﬂ/ﬂPodocin-cre, to assess its role in the protective effect of
CLEC-2 on glomerular function and structure. Genetic deletion
of podoplanin on podocytes was conﬁrmed by immuno-
ﬂuorescence (Fig. 3a, star), with podoplanin expression main-
tained on parietal epithelial cells (Fig. 3a, arrow). The level of
podoplanin in control mice was slightly decreased in the glo-
meruli in response to LPS with depletion maintained in the
PDPNﬂ/ﬂPodocin-cre+ mice (Fig. 3b). There was no change in
platelet or white blood cell (WBC) counts, albumin or BUN in
unchallenged or following LPS in the PDPNﬂ/ﬂPodocin+ mice
(Fig. 3c–f). These data demonstrate that the protective effect of
platelet CLEC-2 during LPS-induced sepsis is not associated with
upregulation of podoplanin in glomeruli and is not mediated by
podoplanin on renal podocytes.
Platelet CLEC-2 limits inﬂammation during endotoxemia.
Endotoxemia is known to increase pro-and anti-inﬂammatory
cytokines in mice and human, in particular IL-10, IL-6, and TNF-α34.
High expression of IL-10 and TNF-α correlate with poor prog-
nostic in patients with severe sepsis whereas higher levels of TNF-
α, IL-6, and soluble TNF receptor (sTNFR) are associated with
early hemodynamic deterioration35. We therefore investigated the
effect of platelet ITAM receptor deletion on cytokine and che-
mokine expression at 8 h following LPS challenge.
Deletion of CLEC-2 but not GPVI signiﬁcantly increased serum
TNF-α and IL-6, as well as the monocyte chemoattractant,
chemokine (C-C motif) ligand 2 (CCL2), and the neutrophil
chemokines, chemokine (CXC motif) ligand (CXCL)−1 and −2,
compared to wild-type controls (Fig. 4a–e). The increase in IL-6,
CCL-2, and CXCL-2 was also present in CLEC2ﬂ/ﬂPF4cre +GPVI−/−
mice, whereas TNF-α and CXCL-1 were not signiﬁcantly
different from WT in the double-deﬁcient strain, consistent with
the intermediate phenotype described above.
The cytokine levels observed in LPS-treated CLEC-2ﬂ/ﬂPF4cre+
mice were similar to those observed in thrombocytopenic mice
post-LPS. In contrast, CLEC-2 deletion did not alter serum
expression of IL-10 compared to LPS-treated wild-type controls
(Fig. 4f). In order to assess whether the protective effect of CLEC-
2 in the regulation of the inﬂammatory reaction is mediated by its
interaction with its endogenous ligand, podoplanin, wild-type
C57Bl/6 mice were injected with an anti-podoplanin blocking/
crosslinking antibody, mAb 8.1.1, or isotype control 2 h post LPS.
mAb 8.1.1 blocks podoplanin binding to CLEC-2 in vitro
(Supplementary Fig. 5) and in vivo33 and induces crosslinking
of podoplanin thereby potentially altering podoplanin signaling.
Cytokine levels were measured in the blood 8 h post LPS.
Disruption of the CLEC-2-podoplanin axis by administration of
mAb 8.1.1 signiﬁcantly increased expression CCL-2, CXCL-1,
CXCL-2, IL-6, and IL-10 (Fig. 4g–k). No signiﬁcant changes in
TNF-α level was observed (Fig. 4l).
These data suggest that CLEC-2 deletion from platelets
potentiates the acute inﬂammatory response induced by LPS.
This dysregulated reaction is therefore a potential mechanism for
the increased clinical severity observed in thrombocytopenic and
CLEC2ﬂﬂPF4cre+ mice.
CLEC-2 limits organ injury and inﬂammation during CLP.
Injection of LPS reproducibly causes systemic activation of the
innate immune system. However, sepsis in patients is far more
complex triggered both by the infectious process and the
immunological responses to microbial challenge36–38. Therefore,
we used a bacterial model of peritonitis, CLP, to investigate the
role of platelet CLEC-2 during sepsis.
As with the LPS-induced endotoxemia, a signiﬁcant decrease in
platelet and leukocyte count was observed in WT and CLEC2ﬂ/
ﬂPF4cre+ (Supplementary Fig. 6). Platelet-speciﬁc CLEC-2-
deletion signiﬁcantly increased the severity of CLP-induced sepsis
(Fig. 5a) and tissue damage as measured by LDH level in the
blood (Fig. 5b). No signiﬁcant difference in liver ALT levels was
observed (Fig. 5c). In line with this, no signiﬁcant alteration in
thrombus formation in the liver was observed, again consistent
with the absence of podoplanin-positive cells around the vessels
in the liver in this model (Fig. 5e). However, accelerated sepsis-
mediated AKI was observed in CLEC2ﬂ/ﬂPF4cre+ mice with
increased BUN levels and severe glomerular damage with
congestion and cellular necrosis/apoptosis associated with acute
tubular injury (Fig. 5d, f).
Interestingly, bleeding in the peritoneal cavity of CLEC2ﬂ/
ﬂPF4cre+ mice did not signiﬁcantly increase during CLP
indicative of a similar loss in vascular integrity to WT controls
Fig. 1 LPS-induced multiple organ damage is accelerated in platelet-depleted mice. Wild-type (WT) mice were injected with LPS (10mg/kg) for 8 or 24 h. a
Platelet and b white blood cell (WBC) count were measured. Blood serum biochemistry of c lactate dehydrogenase (LDH), d albumin, e liver enzyme
alanine aminotransferase (ALT) and f blood urea nitrogen (BUN) (n= 5 in all groups) were measured. g Representative image of liver section stained with
H&E (n= 5). Yellow arrows indicate thrombi. Scale bar= 100 μm. h Representative kidney section stained for podoplanin (PDPN), platelets (CD41) and
ﬁbrinogen/ﬁbrin (n= 5). Yellow arrow indicates PDPN-positive cells in Bowman’s space and white arrow shows ﬁbrin-platelet thrombi (purple). Bars= 50
μm. i–l Platelet depletion using rat IgG control or anti-mouse GPIbα antibody (1.5 μg/g) was performed 24 h before LPS injection. i Systemic clinical score, j
LDH, k ALT and l BUN were measured in the blood 8 h post LPS (n≥ 5 in all groups). Mean values shown with s.d. error bars. Differences between control
groups and LPS-treated mice were assessed using Mann–Whitney U-test. **p< 0.01, ***p< 0.001
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(Fig. 5g). On the other hand, the increased severity of the clinical
score and kidney damage was associated with an increase in
bacterial load in the PLF and kidney 24 h after CLP compared to
littermate controls (Fig. 5h, i). Bacterial load was not signiﬁcantly
different to controls in the liver, blood, spleen, or lung (Fig. 5j,
Supplementary Fig. 7).
During this early stage of CLP, over 85% of the CD45+
recruited cells into the peritoneal cavity were myeloid cells, as
shown by CD45+CD11b+ staining, with comparable numbers
recruited in CLEC2ﬂ/ﬂPF4cre+ mice and WT controls (Fig. 6a, b).
However, a signiﬁcant increase in the percentage and total number
of neutrophils recruited was observed in CLEC2ﬂ/ﬂPF4cre+ mice
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Fig. 2 CLEC-2 deﬁcient platelet exacerbates septic shock and multiple organ failure. Mice were injected with LPS (10mg/kg) for 8 h and a clinical score
was assessed. Blood serum biochemistry b LDH, c albumin, d BUN, e ALT (n≥ 6 in all groups) were measured. Mean values shown with s.d. error bars. f, g
Representative images of glomeruli in parafﬁn embedded kidney sections of unchallenged f or following 8 h LPS g wild-type (CLEC-2ﬂ/ﬂ), platelet CLEC-2
deﬁcient (CLEC-2ﬂ/ﬂPF4cre+), GPVI−/− and double knock out (CLEC-2ﬂ/ﬂPF4cre + GPVI−/−) mice using Masson’s trichrome stain. Scale bar= 20 μm.
Arrow indicates the presence of epithelial cells and ﬁbrin in Bowman’s space. h Histopathology score for epithelial cell sloughing in the Bowman’s space
used as readout of necrosis/apoptosis and i the absence or presence of thrombi in the glomeruli expressed as means± s.e.m. of 40 glomeruli from 5 mice
in each group. Differences assessed using one-way ANOVA with Tukey’s multiple comparison tests ****p< 0.0001. j Representative images of parafﬁn
embedded kidney cortex sections stained with anti-ﬁbrinogen/ﬁbrin antibody 8 h post LPS. Scale bar= 50 μm. k Representative images of parafﬁn
embedded liver sections stained with H&E. Yellow arrows indicate thrombi bars= 200 μm. l Frozen lung sections stained for leukocytes (CD45) and nuclei
(Hoechst 33342), Scale bar= 100 μm, or m CD45 and podoplanin. Scale bar= 50 μm. (n= 6 for all histology images)
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compared to WT controls (Fig. 6c, d). This was associated with a
signiﬁcant decrease in percentage and total number of macro-
phages recruited to the infected peritoneum in the CLEC2ﬂ/
ﬂPF4cre+ mice (Fig. 6e, f). Within this macrophage population,
podoplanin was expressed at similar levels in WT and CLEC2ﬂ/
ﬂPF4cre+ mice, despite the reduction in actual numbers of
macrophages recruited in CLEC2ﬂ/ﬂPF4cre+ mice (Fig. 6g, h). An
increase in TNF-α, IL-6, IL-10, and CCL-2 expression was also
observed in the sera of CLEC2ﬂ/ﬂPF4cre+ mice compared to their
littermate controls following CLP (Fig. 6i–l).
Taken together these results suggest that platelet CLEC-2
regulates the severity of CLP by controlling the systemic and local
immune response resulting in appropriate immune cell recruit-
ment to the infected peritoneum, efﬁcient bacterial clearance and
limited organ damage.
Podoplanin regulates macrophage recruitment during CLP.
Under inﬂammatory conditions, the activation of platelet CLEC-2
by podoplanin-expressing macrophages induces formation of
platelet-macrophage aggregates and platelet-platelet aggregates
in vitro and in vivo25,26,32. Using a mouse model of
hematopoietic-deletion of podoplanin, PDPNﬂ/ﬂVAVcre+, a sig-
niﬁcant increase in sepsis severity and tissue injury was observed
compared to littermate controls following CLP (Fig. 7a, b). CLP-
induced thrombocytopenia and leukopenia in PDPNﬂ/ﬂVAVcre+
mice was comparable to WT (Supplementary Fig. 8), and no
signiﬁcant decline in liver function or thrombus formation was
observed (Fig. 7c, e).
A signiﬁcant increase in BUN levels in PDPNﬂ/ﬂVAVcre+ mice
was associated with increased kidney injury compared to wild-
type controls (Fig. 7d, f). In addition, a signiﬁcant increase in
bleeding within the peritoneal cavity was observed in PDPNﬂ/ﬂ
VAVcre+ mice compared to controls, indicating that podoplanin
expressed on hematopoietic cells maintains vascular integrity
following infection (Fig. 7g). Moreover, a signiﬁcant increase in
bacterial load in the peritoneal cavity of PDPNﬂ/ﬂVAVcre+ mice
was observed compared to WT controls (Fig. 7h). However, no
signiﬁcant difference in bacterial dissemination to the blood,
kidney, liver, or lung was observed in PDPNﬂ/ﬂVAVcre+ post
CLP compared to WT controls (Fig. 7i–l).
Recruitment of CD11b+-expressing myeloid cells to the
inﬂamed peritoneum in PDPNﬂ/ﬂVAVcre+ mice was above sham
controls but comparable to control post-CLP (Fig. 8a, b). No
signiﬁcant difference in neutrophil recruitment was observed post
CLP in PDPNﬂ/ﬂVAVcre+ mice (Fig. 8c, d). However, the
percentage and total number of macrophages recruited was
reduced (Fig. 8e, f). Further, the percentage of macrophages
expressing podoplanin is signiﬁcantly reduced in PDPNﬂ/
ﬂVAVcre+ mice, conﬁrming deletion by the VAV1-driven cre
recombinase (Fig. 8g). Although macrophage recruitment was
altered in PDPNﬂ/ﬂVAVcre+ mice, the inﬂammatory status was
largely unchanged during CLP as assessed by expression of
TNF-α, CCL-2 and CXCL-1 (Fig. 8i–k). A signiﬁcant increase was
only observed in IL-10 expression in the PLF following CLP in
PDPNﬂ/ﬂVAVcre+ mice compared to controls (Fig. 8l).
Podoplanin expression on macrophages in WT control mice
varies post CLP (18–60%; Fig. 8g). In addition, the percentage of
F4/80+ macrophages recruited was found to inversely correlate
with the clinical score (Fig. 8h). We, therefore, tested whether
podoplanin expression affects the phagocytic and bactericidal
capacities of macrophages in vitro using bone marrow-derived
macrophages (BMDM) isolated from PDPNﬂ/ﬂVAVcre+ and
control mice. BMDMs were incubating in the presence or absence
of LPS with E. coli bio-particles or with live E. coli CFT73
bacteria. No signiﬁcant differences in E. coli bio-particle uptake or
E. coli killing were observed (Supplementary Fig. 9).
Together these data suggest that podoplanin expression on
hematopoietic cells plays a role in regulating macrophage
recruitment to the infected peritoneum during CLP, modulating
bacterial load in the peritoneal cavity and limiting subsequent
organ damage.
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Podoplanin regulates inﬂammation in vitro and in vivo.
Cytokines constitute a double-edged sword in infection; while
immune cell recruitment and cytokine production is crucial to
clear bacteria, excessive production can induce multiple organ
damage39–41. In both LPS-induced and CLP-induced sepsis
models, TNF-α level, as well as other cytokines, was signiﬁcantly
increased in platelet CLEC-2-deﬁcient animals compared to their
littermate controls. Interestingly, TNF-α levels were not altered in
the presence of an anti-podoplanin antibody. TNF-α is expressed
predominantly by neutrophils and inﬂammatory macrophages,
and both platelets and platelet releasate have been shown to
reduce secretion of TNF-α by macrophages in response to high
dose LPS13. It has been previously shown using the RAW 264.7
macrophage cells that LPS upregulates podoplanin expression26.
We therefore investigated whether podoplanin on macrophages
modulates TNF-α secretion.
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m. (n= 7 for each group). Differences assessed using one-way ANOVA with Tukey’s multiple comparison tests. *p< 0.05, **p< 0.01, ***p< 0.001. g–l 2 h
post LPS, α-PDPN (100 μg/mouse) or Syrian hamster IgG (IgG control) were injected i.v. into WT mice. Pro- and anti-inﬂammatory cyto-/chemokines g
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In line with previous ﬁndings, we observed an upregulation of
podoplanin on BMDM in the presence of high dose of LPS (1 μg/
ml) (Fig. 9a). We used the anti-podoplanin mAb 8.1.1 to
investigate the role of podoplanin in the regulation of TNF-α
secretion from BMDM induced by LPS. mAb 8.1.1 blocks
podoplanin binding to CLEC-2 in vitro (Supplementary Fig. 5)
and in vivo33 and induces crosslinking of podoplanin thereby
potentially altering podoplanin signaling. A signiﬁcant decrease
in TNF-α secretion from macrophages was observed in the
presence of mAb 8.1.1 compared to controls (Fig. 9b). This was
associated with a signiﬁcant decrease in the pro-inﬂammatory M1
marker inducible nitric oxide synthase (iNOS) as assessed by ﬂow
cytometry (Fig. 9c).
As disruption of CLEC-2-podoplanin axis during endotoxemia
partially mimics the phenotype observed in CLEC2ﬂ/ﬂPF4cre+
mice, we assessed the role of anti-podoplanin antibody on the
inﬂammatory reaction and immune cell recruitment during
bacterial peritonitis. Wild-type, C57Bl/6, mice were injected i.v.
with mAb 8.1.1(100 μg per mouse) 2 h post CLP. Injection of the
anti-podoplanin antibody moderately increased the clinical
severity (Fig. 9d). This effect was associated with an increase in
CXCL-1, CCL-2 and IL-6 levels in the peritoneal cavity
(Fig. 9e–g). The levels of TNF-α and IL-10 were not altered in
the presence of the podoplanin antibody. Despite an increase in
cytokines and chemokines, there was a signiﬁcant decrease in the
recruitment of CD45+CD11b+-expressing myeloid cells recruited
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Fig. 5 Platelet CLEC-2 limits bacterial dissemination and acute kidney injury during bacterial peritonitis. a CLEC2ﬂ/ﬂPF4cre+ mice or littermate controls (n
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to the peritoneum (Fig. 9j–m). Despite these changes, injection of
the anti-podoplanin antibody did not signiﬁcantly alter bacterial
load or the amount of bleeding in the peritoneal cavity (Fig. 9n, o).
These data demonstrate that expression of podoplanin on
inﬂammatory macrophages regulates the expression of TNF-α
in vitro, with disruption of the CLEC-2-podoplanin pathway
in vivo altering cytokine and chemokine expression and cellular
recruitment during CLP. Together, these data conﬁrm that the
CLEC-2-podoplanin axis regulates the inﬂammatory reaction
in vitro and in vivo.
Discussion
In this study we demonstrate that (i) in two independent mouse
models of sepsis, platelets limit the clinical severity via the platelet
ITAM receptor, CLEC-2; (ii) this effect of CLEC-2 is independent
of thrombosis; (iii) the protective role of CLEC-2 is partially
mediated by its interaction with podoplanin expressed on
inﬂammatory macrophages but not kidney podocytes; and (iv)
the CLEC-2-podoplanin interaction regulates immune cells
inﬁltration and the inﬂammatory reaction at the site of infection.
Platelets have been shown to play multiple roles in sepsis, with
the platelet receptors CLEC-2 and GPVI having a critical role
in the maintenance of vascular integrity at sites of inﬂamma-
tion17–20. In addition, platelet CLEC-2 triggers thrombus for-
mation in the liver in mouse models of Salmonella-mediated
infection32 and deep vein thrombosis33 through a process known
as thromboinﬂammation. In both models, podoplanin is up-
regulated in response to the inﬂammatory reaction and becomes
exposed at sites of breach in the vessel wall leading to platelet
activation and thrombus generation. In the present study, we
show for the ﬁrst time a role for platelet CLEC-2 in the regulation
of the inﬂammatory reaction independent of an effect on
thrombosis, showing that the podoplanin-CLEC-2 axis plays a
role both in inﬂammation and in inﬂammation-driven throm-
bosis (thromboinﬂammation).
In this study, we demonstrate that the podoplanin-CLEC-2 axis
plays a protective role in sepsis by controlling the cytokine/che-
mokine storm following infection limiting organ damage. In
addition, platelet CLEC-2 regulates immune cell inﬁltration at the
site of infection and promotes macrophage recruitment leading to
the control of bacterial load in the infected peritoneum. In con-
trast, GPVI appears to have an opposing role: GPVI-deﬁcient
mice had a similar response to wild-type controls, with the
double-deﬁcient mice having an intermediate phenotype in
regard to multiple organ damage relative to platelet-speciﬁc
CLEC-2-deﬁcient mice. Consistent with these results, a recent
study by Pierre S et al.42, demonstrated that GPVI promotes the
pro-inﬂammatory phenotype of macrophages during cutaneous
inﬂammation. Whether GPVI, via its interaction with tissue
collagen and/or ﬁbrin, modulates the inﬂammatory reaction
during sepsis by altering immune cell activation is the focus of
ongoing studies.
Our data show a beneﬁcial role of platelet CLEC-2 during
sepsis that is independent of thrombosis, as there was no sig-
niﬁcant difference in thrombus formation in kidney or liver
vessels in the absence of platelet CLEC-2. The absence of a role of
CLEC-2 in thrombus formation is consistent with the lack of
peri-vascular podoplanin expression which is currently the only
known ligand for CLEC-2. In LPS- or CLP-induced sepsis
models, inhibition of thrombus formation does not improve
organ damage or survival43,44, further emphasizing that the
present results are independent of a role of CLEC-2 in thrombus
formation. Recently, neutrophil extracellular traps (NETS) were
shown to promote intravascular coagulation and microvascular
damage in sepsis9,45. These results, combined with ours, highlight
the complex interplay of the inﬂammatory reaction and throm-
bosis in sepsis.
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Fig. 6 Platelet CLEC-2 regulates the inﬂammatory response during bacterial peritonitis. CLEC2ﬂ/ﬂPF4cre+ or their littermate control mice following cecal
ligation and puncture (CLP) for 24 h (n= 12). Immune cell recruitment to the peritoneal cavity was assessed by ﬂow cytometry. a Percentage and b total
number of myeloid cells (CD45+CD11b+) from CD45+ cells in peritoneal lavage ﬂuid (PLF). c Percentage and d total number of neutrophils (CD45+CD11b
+Ly6G+) in PLF. e Percentage and f total number of macrophages (CD45+CD11b+F4/80+) in PLF. g Percentage of macrophages expressing podoplanin, h
Median ﬂuorescence intensity (MFI) of podoplanin expressed on macrophages. i TNF-α, j IL-6, k IL-10, and l CCL-2 levels detected in the PLF. Data are
means± s.d. (n= 7 mice in CLP groups, n= 4 in sham group). Differences between control and CLEC2ﬂ/ﬂPF4cre+ was assessed using Mann–Whitney U-
test. *p< 0.05, **p< 0.01. ***p< 0.001
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In both sepsis models, clinical severity was associated with a
signiﬁcant increase in organ damage, in particular AKI in the
absence of platelet CLEC-2. This may be related to the early time
points used given that the kidney is the ﬁrst organ to show
damage in septic patients, with death usually caused by AKI46.
The CLEC-2 ligand, podoplanin is highly expressed by glo-
merular podocytes21. Nevertheless, using targeted deletion of
podoplanin, we show that the protective role of platelet CLEC-2 is
not mediated by podoplanin on podocytes. Rather, our data
support a role for podoplanin on inﬂammatory macrophages in
reducing the bacterial load in the peritoneum.
Bacterial dissemination, the cyto-/chemokine proﬁle, and
recruitment of neutrophils to the peritoneum differed in PDPNﬂ/ﬂ
VAV1cre+ compared to CLEC2ﬂ/ﬂPF4cre+ mice during CLP.
These data suggest that the underlying mechanism is not solely
due to the interaction of podoplanin on hematopoietic cells and
CLEC-2 on platelets and could therefore involve the interaction
of podoplanin with additional ligands or podoplanin expres-
sed on other cell types.
It is unclear whether the podoplanin-CLEC-2 axis limits sepsis
through parallel mechanisms, namely (i) the activation of plate-
lets; (ii) the interaction with podoplanin on inﬂammatory mac-
rophages increasing platelet-macrophage aggregation and
bacterial trapping, and (iii) controlling the inﬂammatory response
via a macrophage-dependent mechanism and thereby allowing
efﬁcient macrophage recruitment to the site of infection. There
are also a variety of cells that express podoplanin that could be
involved including epithelial, stromal and lymphatic endothelial
cells. The presence of multiple mechanisms for CLEC-2 and
podoplanin in regulating macrophage functions and the presence
of multiple cells is the focus of ongoing research.
In this study, we show that anti-podoplanin antibody, mAb
8.1.1, modulates the inﬂammatory reaction following sepsis. Our
in vitro data demonstrate that podoplanin expressed on inﬂam-
matory macrophages regulates not only platelet aggregation, but
also macrophage TNF-α secretion. In vitro, mAb 8.1.1decreases
TNF-α secretion from LPS-treated BMDM. However, in vivo,
injection of the anti-podoplanin antibody inhibits immune cell
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recruitment to the infected peritoneum despite an increase in
pro-inﬂammatory cytokines and chemokines. Of note, relatively
high concentrations of mAb 8.1.1 were required to block the
interaction of podoplanin and CLEC-2 in vitro. This may explain
the intermediate phenotype observed in vivo relative to that
observed in platelet CLEC-2 deﬁcient mouse models.
Importantly, the anti-podoplanin antibody regulates the
inﬂammatory reaction and immune cell inﬁltration during sepsis
without inducing bleeding in the peritoneal cavity. Thus, the anti-
podoplanin antibody represents a novel way to modulate the
inﬂammatory reaction and immune cell inﬁltration in a manner
that is dependent on podoplanin expression. As inﬂammation is
also required for efﬁcient bacterial clearance, the selective mod-
ulation of the inﬂammatory system is essential to prevent an
uncontrolled bacteraemia.
One potential limitation of this study is the use of PF4 cre to
generate platelet-speciﬁc CLEC-2-deﬁcient mice. A recent study
has shown that the PF4-driven cre recombinase is expressed on a
subset of immune cells and on a small subset of activated DCs in
mesenteric lymph nodes following exposure to LPS47.
In conclusion, this study suggests a novel mechanism for the
protective role of platelets in sepsis through the ITAM receptor
CLEC-2. We demonstrate, in two mouse models of sepsis, that
platelet CLEC-2 limits clinical severity of sepsis by potentially
controlling multiple parameters including monocyte/macrophage
migration to the site of infection, inﬂammatory mediator
expression, limiting bacteremia and organ damage. These con-
clusions are based on the use of platelet-speciﬁc CLEC-2-deﬁcient
mice or by pharmacological inhibition of CLEC-2-podoplanin
interaction using an anti-podoplanin antibody. Our study high-
lights a new role for platelets in regulating innate immunity
during infection through the podoplanin-CLEC-2 axis.
Methods
Mice. All experiments were performed in accordance with UK laws (Animal
[Scientiﬁc Procedures] Act 1986) with approval of local ethics committee and UK
Home Ofﬁce approval under PPL P0E98D513 and 70/8576 granted to the Uni-
versity of Birmingham. The following mice were used: the ITAM-deﬁcient strains
GPVI−/−, platelet CLEC-2−/− (CLEC2ﬂ/ﬂPF4cre+) and double-deﬁcient (CLEC2ﬂ/ﬂ
PF4cre + GPVI−/−), and mice with targeted deletion of podoplanin in cells of
hematopoietic lineage, PDPNﬂ/ﬂVAV-iCre48–51. Mice expressing the Podocin cre52
were crossed with PDPNﬂ/ﬂ to generate the PDPNﬂ/ﬂPodocin+ strain. All mice
were on a C57Bl/6 background. Wild-type (WT) C57Bl/6 mice were purchased
from Harlan Laboratories (Oxford UK). For intraperitoneal injection of LPS,
12–16 weeks females and males (2:1 ratio) were used. For CLP, 12–16 weeks old
females were used.
LPS-induced endotoxemia. LPS (Escherichia coli 055:B5, Sigma) was diluted in
pyrogen-free saline and injected intraperitoneally to sex and age matched mice. A
clinical score severity was performed after 8 or 24 h based on each animal’s
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appearance, activity, response to stimulation and openness of their eyes (Supple-
mentary Table 1). At 8 or 24 h post injection, blood was collected in ethylene-
diaminetetraacetic acid (EDTA) for blood cell counts or without anticoagulant
using retro-orbital bleeding. Kidneys, livers and lungs were collected.
Cecal ligation and puncture model. Cecal ligation and puncture (CLP) was
performed as described previously53. Brieﬂy, female mice were anaesthetized using
isoﬂurane, the abdominal skin shaved, and under aseptic conditions, a 1 cm
midline incision performed. The cecum was ligated with a silk suture and punc-
tured once through-and-through with a 19 gauge needle. The cecum was then
gently squeezed to exteriorize a drop of feces and returned to the peritoneal cavity.
The laparotomy site was closed with 4.0 silk and animals returned to their cages.
After 24 h, clinical score was assessed as previously described54 and blood, peri-
toneal lavage ﬂuid (PLF), liver and kidneys collected. Peritoneal lavage ﬂuid was
collected using 2 ml ice-cold phosphate-buffered saline (PBS) supplemented with
EDTA (10 mM). Hemoglobin was measured in PLF after lysing red cells as pre-
viously described19. Liver (right lobe) and one kidney were homogenized in ice-
cold sterile PBS and the homogenates plated on lysogeny broth (LB) agar to
determine the number of colony forming units (CFU). The other kidney was
processed in parafﬁn for immunohistochemistry. Neutrophil count in the PLF was
measured by ﬂow cytometry using anti CD45, CD11b and Ly6G (clone1A8,
eBiosciences) and macrophages analyzed using anti-F4/80 antibody (eBiosciences).
Podoplanin expression was analyzed using antibody clone 8.1.1 (eBiosciences).
Platelet depletion procedure. Platelets were depleted by i.p. injection of rat anti-
mouse GPIbα antibody (1.5 μg/g for severe thrombocytopenia and 0.3 μg/g for
mild thrombocytopenia; Emfret, Wurzburg, Germany) delivered 24 h before LPS
injection. Rat IgG was used as an isotype control. Blood was collected in EDTA to
measure the level of depletion using an ABX Pentra 60 blood counter (Horbia Ltd,
Northampton, UK).
Blood chemistry and serum cytokines and chemokines. For blood chemistry
and cytokine measurements, whole blood was collected without anticoagulant,
incubated for 1 h at 37 °C and serum isolated by centrifugation at 2000×g for 30
min. Blood urea nitrogen (BUN), blood albumin, lactate dehydrogenase (LDH),
and alanine transferase (ALT) were measured on an AU680 clinical chemistry
analyzer (Beckman Coulter, High Wycombe, UK) using reagents and settings
recommended by the manufacturer. All cytokines and chemokines in the blood
and PLF were analyzed using Fluorokine MAP Multiplex (R&D systems, Abing-
don, UK).
Histology and immunohistochemistry. For frozen sections, the renal capsule was
removed and kidneys bisected. They were then ﬁxed initially in 4% paraf-
ormaldehyde (PFA) for 2 h, subsequently transferred into 20% sucrose overnight
and frozen in optimum cutting temperature (OCT) compound (Tissue-Tek, The
Netherlands). For immunohistochemistry, kidneys were ﬁxed overnight in 4%
PFA, dehydrated and embedded in parafﬁn. Livers were snap-frozen in liquid
nitrogen. Lungs were infused in situ, post-mortem with 1.5 ml of a solution con-
taining OCT in PBS (1:2) introduced via the trachea using a 19G needle. The
trachea was then sutured and lungs removed en bloc and frozen over dry ice. Lung
and liver sections (12 μm) and kidney sections (6 μm) were processed for immu-
noﬂuorescence staining or immunohistochemistry. Masson’s trichrome stain
(Abcam, Cambridge, UK) and Martius Scarlet Blue stain (Atom Scientiﬁc, Hyde
Cheshire, UK) were applied on parafﬁn sections. Anti-mouse podoplanin mono-
clonal antibody (mAb, clone 8.1.1), anti-mouse mAb CD45 (Clone 30-F11) (all
from eBiosciences), anti-mouse mAb CD41 (Clone MWReg30, BD biosciences),
and anti-ﬁbrin/ﬁbrinogen (no. YNGMFBG7,Accurate chemical and scientiﬁc Co,
NY, USA) (all used at ﬁnal concentration of 5 µg/ml) were used for immuno-
ﬂuorescence on frozen sections. Images were analyzed using a Zeiss confocal
microscope or Zeiss Axio Scan.Z1 microscope and ZEN software or by confocal
microscopy. Glomerular changes were assessed on blinded sections based on 40
glomeruli per kidney. Two histological features were evaluated as present or absent:
glomerular congestion with or without thrombi and sloughing of epithelial cells in
the Bowman’s space consistent with necrosis/apoptosis.
Platelet and macrophage preparation and co-culture. Washed platelets were
prepared as previously described55. Bone marrow-derived macrophages (BMDMs)
were prepared as previously described with some modiﬁcations56. Brieﬂy, bone
marrow cells were plated at 106 per ml in 20% L-929 cell conditioned media. After
7 days in culture, BMDMs were washed and activated with LPS (1 μg/ml) for 18 h.
Cells were scraped and podoplanin expression assessed by ﬂow cytometry on an
Accuri C6 Plus (BD Biosciences, Oxford, UK) using PE conjugated anti-
podoplanin antibody (mAb 8.1.1). For co-culture experiments, anti-podoplanin
antibody (mAb 8.1.1) (10 μg/ml) or isotype control were added for 24 h in the
presence of LPS (1 μg/ml). TNF-α in the supernatant was measured by ELISA
(Peprotech, London, UK). The RAW 264.7 macrophage cell line was obtained from
ATCC (Manassas, VA) and routinely tested for mycoplasma. The recombinant
chimera protein mouse CLEC-2-Fc was produced from pFuse-Fc-CLEC2 stable
transfected 293T cell line and shown to bind to podoplanin-positive RAW 264.7
cells using ﬂow cytometry.
Macrophage phagocytosis and bacterial killing. Phagocytosis: BMDM
(untreated or treated with 1 μg/ml of LPS for 24 h, 105 cells/condition) were
incubated with Alexa Fluor 488 conjugate-Escherichia coli (K-12 strain) Bio-
Particles (3 × 106 particles/per condition) for 60 min at 37 °C. Phagocytosis was
assessed using ﬂow cytometry.
Bacterial killing: BMDM (untreated or treated with 1 μg/ml of LPS for 24 h, 106
cells/ml) were incubated with E.coli CFT73 live bacteria (108 CFU of bacteria) for
30 or 60 min in the absence of antibiotics at 37 °C. Cells were washed, lysed with
water and plated in serial dilutions on LB agar overnight. The number of CFU was
counted to measure bacterial killing compared to bacteria alone and subtracted
from the total number.
Data analysis. All data were presented as means± s.d or s.e.m. The signiﬁcant
difference between two groups was evaluated using a Mann–Whitney U-test, and
the signiﬁcance between three groups analyzed using a two-way ANOVA with
Tukey’s multiple comparisons test using Prism 7 (GraphPad Software Inc, USA).
Data availability. All data are available from the corresponding author upon
reasonable request.
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